Gene · 2010
EMD: emerin
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. EMD: emerin. Genes, record 2010. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/2010
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P50402 | Emerin | 254 | 6 | Ensembl, GeneID, HGNC |
Source UniProt
Patents21
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 44923 | P50402 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 8678 | P50402 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 1388 | P50402 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 1388 | P50402 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 8678 | P50402 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 27163 | P50402 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 130134 | P50402 | Espacenet |
| US 11078247 B2 | 2021-08-03 | 3532 | P50402 | Espacenet |
| JP 2019054813 A | 2019-04-11 | 225358 | P50402 | Espacenet |
| JP 2017121241 A | 2017-07-13 | 225358 | P50402 | Espacenet |
1 to 10 of 21
See all 21 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,121
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | EMD papers | Newest fiscal year |
|---|---|---|---|
| R01AG011085 | Ubiquitin‐mediated proteolysis and cell cycle control | 6 | 2025 |
| T32HL007381 | Cardiovascular Sciences Training Grant | 6 | 2025 |
| R01GM105672 | The mechanism of ESCRT-mediated surveillance of the nuclear envelope barrier | 5 | 2025 |
| T32HL007227 | Pathophysiology of Myocardial Disease | 5 | 2025 |
| ZIANS003129 | Molecular and Clinical Manifestations of Matrix and Aggregate Myopathies | 5 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 4 | 2025 |
| P30CA013696 | Cancer Center Support Grant | 4 | 2025 |
| ZIABC010309 | Nuclear Architecture and Disease | 4 | 2025 |
| P20GM103408 | Idaho INBRE Program | 3 | 2025 |
| P30AG021334 | Older Americans Independence Center | 3 | 2025 |
1 to 10 of 1,121Source NIH's project files
See all 1,121 nih grantsPapers1,970
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Emerin loss of function inhibits MyoD-driven differentiation of human iPSCs into skeletal myotubes. | bioRxiv | 2026 | 42779675 | PubTator, text mining | PubMed |
| How Mechanical Forces at the Nuclear Envelope Regulate Yki/YAP Localization. | Cold Spring Harb Perspect Biol | 2026 | 42674842 | PubTator, text mining | PubMed |
| Emerin acts as a mechanosensor linking force transmission and disease. | Front Oncol | 2026 | 42597750 | PubTator, text mining | PubMed |
| Autoantibodies to the nuclear envelope: Functional anatomy of the HEp-2 cell substrate. | Autoimmun Rev | 2026 | 42567391 | PubTator, text mining | PubMed |
| Elevation of the mechanically-sensitive e protein emerin links nuclear mechanotransduction to tau-induced cytoskeletal remodeling in neurons. | Nucleus | 2026 | 42415348 | PubTator, text mining | PubMed |
| Participation of the purinergic P2X7 receptor in molecular complexes in the nucleus of human chondrocytes. | Cell Mol Life Sci | 2026 | 42307773 | PubTator, text mining | PubMed |
| A Novel Emerin/Nesprin-3 Interaction Mediates Nuclear Size Changes Induced by Oncogenic KRAS in Pancreatic Cancer Cells. | Mol Cell Biol | 2026 | 42175908 | PubTator, text mining | PubMed |
| Sequence and structural alignments reveal insights into ANKLE2 evolution and function. | Protein Sci | 2026 | 42141523 | PubTator, text mining | PubMed |
| Emerin is necessary for microtubule-organizing center translocation to the nuclear envelope of muscle cells. | Cell Death Dis | 2026 | 42120880 | PubTator, text mining | PubMed |
| Nuclear envelope proteins in cancer: revisiting the significance of LEM-domain proteins. | Front Cell Dev Biol | 2026 | 42099394 | PubTator, text mining | PubMed |
1 to 10 of 1,970
See all 1,970 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/2010
GET https://conductscience.org/api/genes/v1/2010/patents?page=2